 left ventricular eject fraction use end point thrombolyt therapi compar trial era compar adjunct trial reperfus therapi need altern end point mortal reduct clear left ventricular eject fraction surrog problemat due valu inadequ studi lack correl mortal result control reperfus trial date paper composit clinic end point order sever advers outcom death hemorrhag stroke nonhemorrhag stroke poor eject fraction reinfarct heart failur pulmonari edema composit index use true therapeut benefit reperfus trial patient enrol